Title: Azilsartan and its Zn(II) complex. Synthesis, anticancer mechanisms of action and binding to bovine serum albumin.
Journal: Toxicology in vitro : an international journal published in association with BIBRA 20180401
Title: Efficacy and safety of 10-mg azilsartan compared with 8-mg candesartan cilexetil in Japanese patients with hypertension: a randomized crossover non-inferiority trial.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension 20140901
Title: Evaluation of the efficacy and tolerability of fixed-dose combination therapy of azilsartan and amlodipine besylate in Japanese patients with grade I to II essential hypertension.
Journal: Clinical therapeutics 20140501
Title: Assessment of the environmental fate and effects of azilsartan, a selective antagonist of angiotensin II type 1.
Journal: Chemosphere 20120601
Title: Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I-II essential hypertension: a randomized, double-blind clinical study.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension 20120501
Title: Differential pharmacology and benefit/risk of azilsartan compared to other sartans.
Journal: Vascular health and risk management 20120101
Title: Critical evaluation of the efficacy and tolerability of azilsartan.
Journal: Vascular health and risk management 20120101
Title: Clinical utility of azilsartan-chlorthalidone fixed combination in the management of hypertension.
Journal: Vascular health and risk management 20120101
Title: Azilsartan treatment improves insulin sensitivity in obese spontaneously hypertensive Koletsky rats.
Journal: Diabetes, obesity & metabolism 20111201
Title: Comparison of the novel angiotensin II receptor blocker azilsartan medoxomil vs valsartan by ambulatory blood pressure monitoring.
Journal: Journal of clinical hypertension (Greenwich, Conn.) 20110701
Title: In vitro antagonistic properties of a new angiotensin type 1 receptor blocker, azilsartan, in receptor binding and function studies.
Journal: The Journal of pharmacology and experimental therapeutics 20110301
Title: Azilsartan: a newly approved angiotensin II receptor blocker.
Journal: Cardiology in review 20110101
Title: TAK-536, a new AT1 receptor blocker, improves glucose intolerance and adipocyte differentiation.
Journal: American journal of hypertension 20070501
Title: Ojima M, Igata H, Tanaka M, In vitro antagonistic properties of a new angiotensin type 1 receptor blocker, azilsartan, in receptor binding and function studies. J Pharmacol Exp Ther. 2011 Mar;336(3):801-8.
Title: Weltman R, Brands CM, Corral E, Assessment of the environmental fate and effects of azilsartan, a selective antagonist of angiotensin II type 1. Chemosphere. 2012 Jun;87(11):1323-9.
Title: Pierini D, Anderson KV. Azilsartan medoxomil/chlorthalidone: a new fixed-dose combination antihypertensive. Ann Pharmacother. 2013 May;47(5):694-703.
Title: Iwai M, Chen R, Imura Y, Horiuchi M. TAK-536, a new AT1 receptor blocker, improves glucose intolerance and adipocyte differentiation. Am J Hypertens. 2007 May;20(5):579-86.
